Athan Kuliopulos Selected Research

PAR-1 Receptor

12/2020	PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.
7/2018	Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.
6/2011	Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury.
8/2009	Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis.
12/2007	'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.
3/2006	Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
3/2006	Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Athan Kuliopulos Research Topics

Disease

13	Thrombosis (Thrombus) 01/2021 - 11/2003
12	Neoplasms (Cancer) 07/2018 - 03/2006
9	Inflammation (Inflammations) 01/2021 - 11/2003
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2016
4	Acute Coronary Syndrome 12/2020 - 01/2005
4	Sepsis (Septicemia) 01/2013 - 06/2005
3	Non-alcoholic Fatty Liver Disease 12/2022 - 10/2016
3	Hemorrhage 01/2021 - 12/2004
3	Necrosis 12/2020 - 07/2012
3	Ovarian Neoplasms (Ovarian Cancer) 07/2018 - 07/2010
3	Vascular System Injuries 08/2013 - 06/2011
3	Neoplasm Metastasis (Metastasis) 07/2012 - 08/2009
2	Fibrosis (Cirrhosis) 12/2022 - 10/2016
2	Atherosclerosis 01/2021 - 01/2018
2	Myocardial Infarction 01/2020 - 06/2011
2	Hyperplasia 12/2011 - 09/2006
2	Disseminated Intravascular Coagulation 07/2011 - 06/2005
2	Breast Neoplasms (Breast Cancer) 08/2009 - 03/2006
1	Insulin Resistance 12/2022
1	Carotid Artery Injuries 01/2021
1	Peripheral Arterial Disease 01/2020
1	Bulimia (Binge Eating) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Pruritus (Itching) 01/2019
1	Dermatitis 01/2019
1	Alcoholic Fatty Liver 01/2017
1	Alcoholic Hepatitis 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016
1	Liver Diseases (Liver Disease) 10/2016
1	Pathologic Constriction (Stenosis) 08/2013
1	Rupture 08/2013
1	Heart Failure 01/2013
1	Lewis Lung Carcinoma 07/2012
1	Carcinogenesis 07/2012
1	Melanoma (Melanoma, Malignant) 07/2012
1	Lymphoid Leukemia 02/2012
1	Lymphoma (Lymphomas) 02/2012
1	Hematologic Neoplasms (Hematological Malignancy) 02/2012

Drug/Important Bio-Agent (IBA)

11	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 04/2010
9	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019 - 02/2005
9	Thrombin FDA Link 01/2018 - 11/2003
7	Metalloproteases (Metalloproteinases)IBA 01/2021 - 09/2008
7	PAR-1 ReceptorIBA 12/2020 - 03/2006
4	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 03/2006
4	Thrombin Receptors (Thrombin Receptor)IBA 07/2012 - 04/2002
4	Proteinase-Activated ReceptorsIBA 09/2008 - 02/2005
3	Clopidogrel (Plavix)FDA Link 01/2020 - 07/2012
3	GTP-Binding Proteins (G-Protein)IBA 07/2012 - 09/2008
2	PAR-2 ReceptorIBA 12/2022 - 11/2019
2	LipidsIBA 01/2021 - 11/2019
2	Collagenases (Collagenase)FDA Link 01/2021 - 07/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 12/2004
2	bivalirudin (Angiomax)FDA Link 05/2019 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 06/2005
2	CollagenIBA 10/2016 - 07/2012
2	Bevacizumab (Avastin)FDA Link 04/2013 - 07/2011
2	Chemokine ReceptorsIBA 02/2012 - 06/2005
2	PZ-128 peptideIBA 07/2011 - 08/2009
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 07/2011 - 03/2006
2	Interleukin-8B ReceptorsIBA 07/2010 - 06/2005
2	ChemokinesIBA 07/2010 - 06/2005
2	LipopeptidesIBA 08/2009 - 06/2005
2	LigandsIBA 06/2005 - 11/2003
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	ferric chlorideIBA 01/2021
1	vorapaxarIBA 01/2020
1	APTIBA 01/2020
1	11-dehydro-thromboxane B2IBA 01/2020
1	FibrinIBA 01/2020
1	CholesterolIBA 11/2019
1	Prasugrel Hydrochloride FDA Link 05/2019
1	Peptides (Polypeptides)IBA 01/2019
1	OxazoloneIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Wasp Venoms (Venom, Wasp)IBA 01/2019
1	Trace amine-associated receptor 1IBA 01/2019
1	DinitrofluorobenzeneIBA 01/2019
1	Pharmaceutical PreparationsIBA 07/2018
1	Interleukin-8 ReceptorsIBA 01/2017
1	CytokinesIBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016
1	Alanine Transaminase (SGPT)IBA 10/2016
1	Choline (Choline Chloride)IBA 10/2016
1	Methionine (L-Methionine)FDA Link 10/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2016
1	Triglycerides (Triacylglycerol)IBA 10/2016
1	Enzyme Precursors (Zymogens)IBA 12/2014
1	matrigelIBA 04/2013
1	Immunoglobulin G (IgG)IBA 04/2013
1	Monoclonal AntibodiesIBA 04/2013
1	Matrix Metalloproteinase InhibitorsIBA 01/2013
1	Hemostatics (Antihemorrhagics)IBA 07/2012

Therapy/Procedure

9	Therapeutics 12/2020 - 01/2005
5	Percutaneous Coronary Intervention 05/2019 - 12/2004
2	Glycemic Control 12/2022 - 01/2019
2	Stents 05/2019 - 01/2013
1	Intravenous Infusions 01/2016
1	Immunotherapy 02/2012